Skip to content

Drug interactions

Letrozole + Mavacamten

Severity: Moderate

Letrozole and Mavacamten: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letrozole may inhibit CYP2C19 to a modest degree and could raise mavacamten exposure. Mavacamten has a narrow therapeutic window, and higher exposure can reduce left ventricular ejection fraction and cause heart failure.

What this interaction means in plain words

Letrozole and Mavacamten can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Letrozole belongs to Oncology; Mavacamten belongs to Cardiovascular.

Evidence level: Low

Why it happens

Inhibition of CYP2C19-mediated mavacamten metabolism by letrozole, which reduces clearance.

What to do

Monitor echocardiographic LVEF and clinical status when letrozole is started or stopped during mavacamten therapy. Adjust the mavacamten dose per labeling if LVEF falls or symptoms of heart failure appear.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Letrozole and Mavacamten, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Letrozole with Mavacamten?

MediHelp rates the interaction as moderate. Letrozole and Mavacamten can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Letrozole may inhibit CYP2C19 to a modest degree and could raise mavacamten exposure. Mavacamten has a narrow therapeutic window, and higher exposure can reduce left ventricular ejection fraction and cause heart failure.

How serious is the interaction between Letrozole and Mavacamten?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor echocardiographic LVEF and clinical status when letrozole is started or stopped during mavacamten therapy. Adjust the mavacamten dose per labeling if LVEF falls or symptoms of heart failure appear.

What other medicines interact with Letrozole?

MediHelp also lists interactions of Letrozole with, for example, Desogestrel-ethinyl estradiol, Ethinyl estradiol-drospirenone, Ethinyl estradiol-levonorgestrel. The full list is on the Letrozole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in